Annette Snejbjerg Bartels
Biomedical Laboratory Scientist
Molecular and Cellular Pharmacology
Jagtvej 160, København Ø
- Published
Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node
Tvedskov, T. F., Bartels, Annette Snejbjerg, Jensen, M., Paaschburg, B., Kroman, N., Balslev, E. & Brünner, N., 2011, In: APMIS Supplementum. 119, 12, p. 844-852 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - associations with histopathology and patients outcome
Jensen, S. A., Vainer, B., Bartels, Annette Snejbjerg, Brunner, N. & Sørensen, J. B., 2010, In: European Journal of Cancer. 46, 18, p. 3233-3242 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome
Jensen, S. A., Vainer, B., Bartels, Annette Snejbjerg, Brünner, N. & Sørensen, Jens Benn, 2010, In: European journal of cancer (Oxford, England : 1990). 46, 18, p. 3233-42 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
Egerod, F. N. S. L., Bartels, Annette Snejbjerg, Fristrup, N., Borre, M., Ørntoft, T. F., Oleksiewicz, M. B., Brunner, N. & Dyrskjøt, L., 2009, In: BMC Cancer. 9, 385, 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue
Usher, P. A., Sieuwerts, A. M., Bartels, Annette Snejbjerg, Lademann, U., Nielsen, H. J., Holten-Andersen, L., Foekens, J. A., Brünner, N. & Offenberg, H. K., 2007, In: Molecular Oncology. 1, 2, p. 205-215 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
Munro, A. F., Bartels, Annette Snejbjerg, Balslev, E., Twelves, C. J., Cameron, D. A., Brünner, N. & Bartlett, J. M., 2013, In: Breast Cancer Research (Online Edition). 15, 2, 8 p., R31.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer: A Danish Breast Cancer Cooperative Group Study
Willemoe, G. L., Hertel, P. B., Bartels, Annette Snejbjerg, Jensen, M., Balslev, E., Rasmussen, B. B., Mouridsen, H. T., Ejlertsen, Bent Laursen & Brunner, N., 2009, In: European Journal of Cancer. 45, 14, p. 2528-2536 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
Steffensen, K. D., Waldstrøm, M., Christensen, R. K., Bartels, Annette Snejbjerg, Brunner, N. & Jakobsen, A., 2010, In: BMC Cancer. 10, 185, 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
Aaberg-Jessen, C., Christensen, K., Offenberg, H. K., Bartels, Annette Snejbjerg, Dreehsen, T., Hansen, S., Schrøder, H. D., Brunner, N. & Kristensen, B. W., 2009, In: Journal of Neuro-Oncology. 95, 1, p. 117-128 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PPARa and PPAR¿ coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats
Egerod, F. L., Svendsen, J. E., Hinley, J., Southgate, J., Bartels, Annette Snejbjerg, Brünner, N. & Oleksiewicz, M. B., 2009, In: Toxicologic Pathology. 37, 7, p. 947-958 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 6090964
Most downloads
-
864
downloads
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
849
downloads
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
687
downloads
Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Published